PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Sánchez Quant, E.S. ; Richter, M. ; Colomé-Tatché, M. ; Martinez Jimenez, C.P.

Single-cell metabolic profiling reveals subgroups of primary human hepatocytes with heterogeneous responses to drug challenge.

Genome Biol. 24:234 (2023)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
BACKGROUND: Xenobiotics are primarily metabolized by hepatocytes in the liver, and primary human hepatocytes are the gold standard model for the assessment of drug efficacy, safety, and toxicity in the early phases of drug development. Recent advances in single-cell genomics demonstrate liver zonation and ploidy as main drivers of cellular heterogeneity. However, little is known about the impact of hepatocyte specialization on liver function upon metabolic challenge, including hepatic metabolism, detoxification, and protein synthesis. RESULTS: Here, we investigate the metabolic capacity of individual human hepatocytes in vitro. We assess how chronic accumulation of lipids enhances cellular heterogeneity and impairs the metabolisms of drugs. Using a phenotyping five-probe cocktail, we identify four functional subgroups of hepatocytes responding differently to drug challenge and fatty acid accumulation. These four subgroups display differential gene expression profiles upon cocktail treatment and xenobiotic metabolism-related specialization. Notably, intracellular fat accumulation leads to increased transcriptional variability and diminishes the drug-related metabolic capacity of hepatocytes. CONCLUSIONS: Our results demonstrate that, upon a metabolic challenge such as exposure to drugs or intracellular fat accumulation, hepatocyte subgroups display different and heterogeneous transcriptional responses.
Impact Factor
Scopus SNIP
Altmetric
12.300
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cytochrome P450 ; Dili ; Drug Metabolism ; Hepatic Steatosis ; Lipid Metabolism ; Liver ; Nafld ; Primary Human Hepatocytes ; Single-cell Transcriptomics; Fatty Liver-disease; Gene-expression; Transcriptional Regulation; Cytochrome-p450 Probes; Hepatic Steatosis; Enzymes; Cocktail; Mechanisms; Midazolam; Risk
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 1474-760X
e-ISSN 1465-6906
Zeitschrift Genome Biology
Quellenangaben Band: 24, Heft: 1, Seiten: , Artikelnummer: 234 Supplement: ,
Verlag BioMed Central
Verlagsort Campus, 4 Crinan St, London N1 9xw, England
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Pioneer Campus (HPC)
Institute of Computational Biology (ICB)
POF Topic(s) 30204 - Cell Programming and Repair
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Pioneer Campus
Enabling and Novel Technologies
PSP-Element(e) G-510005-001
G-554200-001
Förderungen Impuls-und Vernetzungsfonds of the Helmholtz-Gemeinschaft
C.P.M-J at the Helmholtz Pioneer Campus
Projekt DEAL
DOI 10.1186/s13059-023-03075-9
WOS ID 001097526200001
Scopus ID 85174287467
PubMed ID 37848949
Erfassungsdatum 2023-11-28
[➜Korrektur melden]